The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query OKUR owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/OKUR"
Use Arkolith to show who owns OKUR, which funds added or reduced it, and which SEC filings prove each claim.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $16.6M | 4.0M | ▲New +4.0M sh | Q1 2026 | |
| 2 | BVF INC/IL | $8.2M | 2.0M | ▲New +2.0M sh | Q1 2026 | |
| 3 | Vestal Point Capital, LP | $7.6M | 1.8M | ▲+190% Added · +1.2M sh | Q1 2026 | |
| 4 | NEA Management Company, LLC | $2.0M | 479K | —Held | Q1 2026 | |
| 5 | Sofinnova Investments, Inc. | $587K | 142K | ▲New +142K sh | Q1 2026 | |
| 6 | NewEdge Advisors, LLC | $184K | 45K | ▲New +45K sh | Q1 2026 | |
| 7 | VANGUARD FIDUCIARY TRUST CO | $180K | 43K | ▲New +43K sh | Q1 2026 | |
| 8 | CITADEL ADVISORS LLC | $156K | 38K | ▼−83% Reduced · −186K sh | Q1 2026 | |
| 9 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | $67K | 16K | ▼−16% Reduced · −3K sh | Q1 2026 | |
| 10 | STATE STREET CORP | $56K | 13K | ▲New +13K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Ratcliffe Liam | Director | Grant (A) | 1K | $0 |
| Jun 4, 2026 | Phillips Andrew John | Director | Grant (A) | 8K | $0 |
| Jun 4, 2026 | Jansen Valerie Malyvanh | Director | Grant (A) | 8K | $0 |
| Jun 4, 2026 | GREY MICHAEL G | Director | Grant (A) | 8K | $0 |
| Jun 4, 2026 | Carruthers R Michael | Director | Grant (A) | 8K | $0 |
| Jun 4, 2026 | Mathers Edward T | Director | Grant (A) | 8K | $0 |
| Mar 23, 2026 | Leverone Jason A. | Chief Financial Officer | Sell (S) | 301 | $1K |
| Mar 23, 2026 | Saccomano Nicholas A | President and CEO, Director | Sell (S) | 86 | $358 |
| Dec 31, 2025 | Manke Isaac | Director | Grant (A) | 5K | $0 |
| Dec 31, 2025 | Mathers Edward T | Director | Grant (A) | 4K | $0 |
| Dec 22, 2025 | Leverone Jason A. | Chief Financial Officer | Sell (S) | 302 | $897 |
| Dec 22, 2025 | Saccomano Nicholas A | President and CEO, Director | Sell (S) | 87 | $258 |
| Company | Co-held by | Combined value |
|---|---|---|
| UNITED THERAPEUTICS CORPUTHR | 6 funds | $356.1M |
| DISC MEDICINE INCIRON | 6 funds | $294.0M |
| MIRUM PHARMACEUTICALS INCMIRM | 6 funds | $275.6M |
| OLEMA PHARMACEUTICALS INCOLMA | 6 funds | $138.5M |
| 4D MOLECULAR THERAPEUTICS INFDMT | 6 funds | $76.8M |
| ANTERIS TECHNOLOGIES GLOBALAVR | 6 funds | $40.2M |
| BLACK DIAMOND THERAPEUTICS IBDTX | 6 funds | $12.1M |
| TYRA BIOSCIENCES INCTYRA | 5 funds | $553.4M |
| BIOMARIN PHARMACEUTICAL INCBMRN | 5 funds | $502.4M |
| ELI LILLY & COLLY | 5 funds | $418.5M |
| ARCELLX INCACLXGBX | 5 funds | $352.2M |
| JAZZ PHARMACEUTICALS PLCJAZZ | 5 funds | $351.6M |
Ranked by how many of OKUR's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for OKUR. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.